Attovia Therapeutics, Inc. (ATTO)
NASDAQ: ATTO · Real-Time Price · USD
19.86
+0.68 (3.55%)
At close: Aug 14, 2026, 4:00 PM EDT
19.56
-0.30 (-1.51%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Attovia Therapeutics Market Cap
Attovia Therapeutics has a market cap or net worth of $854.56 million as of August 14, 2026.
Market Cap
854.56M
Enterprise Value
726.74M
1-Year Change
n/a
Ranking
Category
Stock Price
$19.86
ChartMarket Cap Chart
Since the IPO on August 5, 2026, Attovia Therapeutics's market cap has increased from $731.49M to $854.56M, an increase of 16.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 854.56M | 3.55% |
| Aug 13, 2026 | 825.30M | 6.20% |
| Aug 12, 2026 | 777.10M | -3.16% |
| Aug 11, 2026 | 802.49M | -6.00% |
| Aug 10, 2026 | 853.70M | -1.64% |
| Aug 7, 2026 | 867.90M | -1.03% |
| Aug 6, 2026 | 876.93M | 19.88% |
| Aug 5, 2026 | 731.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Candel Therapeutics | 896.03M |
| Theravance Biopharma | 879.76M |
| SpyGlass Pharma | 870.99M |
| Obsidian Therapeutics | 862.80M |
| Aclaris Therapeutics | 845.66M |
| Pharming Group | 839.41M |
| Silence Therapeutics | 817.04M |
| DBV Technologies | 814.55M |